Voleon Capital Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-60,235
Closed -$187K 841
2025
Q4
$187K Buy
60,235
+40,735
+209% +$116K ﹤0.01% 730
2025
Q3
$51.3K Buy
+19,500
New +$43K ﹤0.01% 870

Other funds holding GOSS

Voleon Capital Management's GOSS Position: Q1 2026 in Review

Voleon Capital Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 60,235 shares — an estimated $187K sold.

Voleon Capital Management first reported a position in GOSS in Q3 2025 and held it in 2 quarters. The position peaked at $187K in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Voleon Capital Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Voleon Capital Management sold 60,235 Gossamer Bio shares in Q1 2026, an estimated $187K.
  • Voleon Capital Management first reported a position in Gossamer Bio in Q3 2025 and held it in 2 quarters.
  • Voleon Capital Management's Gossamer Bio position peaked at $187K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.